Publication | Closed Access

Eugenol alleviated nonalcoholic fatty liver disease in rat via a gut-brain-liver axis involving glucagon-like Peptide-1

Metabolic SyndromeGut-brain-liver AxisHepatologyMedicineLiver PhysiologyPathologyGut-organ AxisGlucagon-like Peptide-1HepatotoxicityLiver DiseaseFatty Liver DiseasePharmacologyGastrointestinal Peptide HormoneHealth Sciences